ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Basic/Clinical Science Session

Untangling Determinants of AKI Through an -Omics Approach, Including the Robert W. Schrier, MD, Endowed Lectureship

November 03, 2022 | 02:00 PM - 04:00 PM

Location: W308, Orange County Convention Center‚ West Building

Session Description

This session discusses how -omics approaches can advance the treatment of AKI by identifying critical pathways and biomarkers and paving the way to precision medicine.

ASN gratefully acknowledges Otsuka America Pharmaceutical, Novartis, Astellas Pharma US, and several individuals for support of the Robert W. Schrier, MD, Endowed Lectureship.

Learning Objective(s)

  • Describe the spatially mapped transcriptomic signature of AKI
  • Discuss applications of proteomics in the treatment of AKI
  • Discuss applications of metabolomics in the treatment of AKI
  • Outline how advances in unbiased tissue interrogation approaches may help to redefine AKI

Learning Pathway(s)

  • AKI and Critical Care


  • Eugene P. Rhee, MD
  • Tomokazu Souma, MD, PhD


  • Spatial Transcriptomics in AKI
    02:00 PM - 02:30 PM
    Eryn E. Dixon, PhD
  • Proteomics in AKI
    02:30 PM - 03:00 PM
    Roman-Ulrich Mueller, MD
  • Metabolomics in AKI
    03:00 PM - 03:30 PM
    Samir M. Parikh, MD, FASN
  • Integrating Analysis of Animal Models and Human Biopsies to Better Understand AKI: The Robert W. Schrier, MD, Endowed Lectureship
    03:30 PM - 04:00 PM
    Lloyd G. Cantley, MD, FASN